Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan.
Department of Global Healthcare, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
Protein Sci. 2023 Sep;32(9):e4744. doi: 10.1002/pro.4744.
Small molecules that regulate protein-protein interactions can be valuable drugs; however, the development of such small molecules is challenging as the molecule must interfere with an interaction that often involves a large surface area. Herein, we propose that modulating the conformational ensemble of the proteins participating in a given interaction, rather than blocking the interaction by directly binding to the interface, is a relevant strategy for interfering with a protein-protein interaction. In this study, we applied this concept to P-cadherin, a cell surface protein forming homodimers that are essential for cell-cell adhesion in various biological contexts. We first determined the crystal structure of P-cadherin with a small molecule inhibitor whose inhibitory mechanism was unknown. Molecular dynamics simulations suggest that the inhibition of cell adhesion by this small molecule results from modulation of the conformational ensemble of P-cadherin. Our study demonstrates the potential of small molecules altering the conformation ensemble of a protein as inhibitors of biological relevant protein-protein interactions.
小分子可以调节蛋白-蛋白相互作用,它们可以成为很有价值的药物;然而,这类小分子的开发极具挑战性,因为这些小分子必须干扰一个通常涉及到很大的表面积的相互作用。在此,我们提出,调节参与特定相互作用的蛋白质构象的整体,而不是通过直接与界面结合来阻断相互作用,是一种干扰蛋白-蛋白相互作用的相关策略。在这项研究中,我们将这一概念应用于 P-钙黏蛋白,这是一种细胞表面蛋白,形成同源二聚体,在各种生物背景下对于细胞间的黏附是必需的。我们首先确定了 P-钙黏蛋白与一种小分子抑制剂的晶体结构,但其抑制机制尚不清楚。分子动力学模拟表明,这种小分子通过调节 P-钙黏蛋白构象的整体来抑制细胞黏附。我们的研究证明了小分子改变蛋白质构象整体作为生物相关蛋白-蛋白相互作用抑制剂的潜力。